Board-certified neurosurgeon with a track record of success as Chief Medical Officer leading the development of new medical innovations from concept to commercial success. Expertise in first-in-human clinical trials with robotic neurosurgery platforms and novel biotechnologies, new FDA “Breakthrough Therapy” designations and category-defining FDA approvals. Business development expertise in forming and leading strategic alliances with biopharma partners, including combination drug-device co-developments in neurological indications. Prior experience includes: as CMO at Insightec, Magnus, Openwater, medical school and neurosurgery training at Stanford University, with academic neurosurgery leadership experience at Stanford, Loma Linda University, John Wayne Cancer Institute and Providence Health System.